A Microfluidic System for Investigating Anticipatory Medication Effects on Dopamine Homeostasis in Dopaminergic Cells
- 19 January 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (6) , 3153-3159
Abstract
Dopamine (DA) homeostasis influences emotions, neural circuit development, cognition, and the reward system. Dysfunctions in DA regulation can lead to neurological disorders, including depression, developmental disorders, and addiction. DA homeostasis disruption is a primary cause of Parkinson's Disease (PD). Therefore, understanding the relationship between DA homeostasis and PD progression may clarify the mechanisms for pharmacologically treating PD. This study developed a novel in vitro DA homeostasis platform which consists of three main parts: (1) a microfluidic device for culturing DAergic neurons, (2) an optical detection system for reading DA levels, and (3) an automatic closed-loop control system that establishes when and how much medication to infuse; this uses a microfluidic device that can cultivate DAergic neurons, perfuse solutions, perform in vitro PD modeling, and continuously monitor DA concentrations. The automatically controlled closed-loop control system simultaneously monitors pharmacological PD treatment to support long-term monitoring of DA homeostasis. SH-SY5Y neuroblastoma cells were chosen as DAergic neurons. They were cultivated in the microfluidic device, and real-time cellular DA level measurements successfully achieved long-term monitoring and modulation of DA homeostasis. When applied in combination with multiday cell culture, this advanced system can be used for drug screening and fundamental biological studies.Keywords
Funding Information
- Ministry of Education (22-BT-06)
- Ministry of Science and ICT, South Korea (2017M3A9G8084463, NRF-2017K1A1A2013237, NRF-2020R1A6A1A03040516, NRF-2020R1F1A1076069)
This publication has 32 references indexed in Scilit:
- Real-Time Dopamine Measurement in Awake MonkeysPLOS ONE, 2014
- Microfluidic devices for cell cultivation and proliferationBiomicrofluidics, 2013
- Monitoring extracellular pH, oxygen, and dopamine during reward delivery in the striatum of primatesFrontiers in Behavioral Neuroscience, 2012
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Review: Deep brain stimulation in Parkinson’s diseaseTherapeutic Advances in Neurological Disorders, 2009
- Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatmentPostgraduate Medical Journal, 2007
- Coordinated Accumbal Dopamine Release and Neural Activity Drive Goal-Directed BehaviorNeuron, 2007
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006
- Long term treatment and disease severity change brain responses to levodopa in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003